Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Stem Cell Sciences and Rhone-Poulenc Rorer enter agreement

Aug. 23, 1999

ImmGenics' SLAM technology presented at conference

Aug. 20, 1999

Medi-Ject proceeds with development of needle-free device for male impotence therapy

Aug. 18, 1999

CAT and HGS enter agreement for therapeutic antibody development

Aug. 17, 1999

Argent gene delivery platform used successfully for sustained, controlled delivery of hGH

Aug. 16, 1999

Creative BioMolecules, NeoGenesis team up to identify new drugs to treat degenerative disorders

Aug. 16, 1999

Immune Complex Corporation awarded SBIR contract to detect cytochrome P450 polymorphisms

Aug. 16, 1999

Aastrom Biosciences enters distribution agreements for Norway and Switzerland

Aug. 16, 1999

Medarex enters antibody development agreement with Eos Biotechnology

Aug. 13, 1999

Dendreon receives FDA premarket approval for stem cell separation device

Aug. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...